Latest news, press releases, articles and announcements.

LAB282 is a £10m+ partnership, created to identify and develop new approaches to treating serious diseases. more
Enzbond launches to make fast, effective enzyme development a reality. more
Why the smart money is investing in University research (paywall). more
Argonaut to develop cancer therapies that reprogram tumours to die. more
Sleep and circadian rhythm disruption addressed by new Oxford spinout Circadian Therapeutics. more
Oxford most prolific university innovator in Europe. more
Oxford spinout Omass to provide native mass-spectrometry to pharma and biotech. more
Record £16.9m for Oxford spinout designing stem cell drugs to treat age-related disease. more
Universal Flu vaccine under development by Oxford spinout Vaccitech. more
EvOx Therapeutics raises £10m for precision system to treat disease. more
Oxford Nanoimaging to provide desktop super-resolution microscopes. more
Oxford machine learning spinout unlocks big data insights. more
Oxford spinout Zegami launches data discovery software to manage ‘information tsunami”. more
Oxford spinout Orbit Discovery launches peptide-discovery platform. more
Oxford Endovascular develop tiny mesh tubes to treat brain aneurysms. more
Bodle to use phase change materials for smart glazing and displays. more
New valve is Oxford Science Innovation’s first investment. more